Search
for
Sort by
Research 961–990 of 1000+
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Evaluation and treatment of male and female pattern hair loss
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Endocrinology of Transgender Medicine
- Metabolic risk in PCOS: phenotype and adiposity impact
- Dermatological adverse events with taxane chemotherapy
- Oxidative stress in ageing of hair
- Keratin 17 null mice exhibit age- and strain-dependent alopecia
- Histopathology of non-scarring alopecia
- Extraskeletal actions of vitamin D
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Platelet-Rich Plasma for Androgenetic Alopecia
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Alopecia Areata Update
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- What causes hidradenitis suppurativa ?—15 years after
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function
- Management of Hair Loss
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Approach to the adult female patient with diffuse nonscarring alopecia
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Dermatoscopic features of central centrifugal cicatricial alopecia
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- How should postmenopausal androgen excess be evaluated?